West Pharmaceutical Services, Inc. (WST)
NYSE: WST · Real-Time Price · USD
320.88
+9.22 (2.96%)
Nov 21, 2024, 4:00 PM EST - Market closed
WST Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 2,876 | 2,950 | 2,887 | 2,832 | 2,147 | 1,840 | Upgrade
|
| Revenue Growth (YoY) | -1.71% | 2.18% | 1.95% | 31.89% | 16.69% | 7.13% | Upgrade
|
| Cost of Revenue | 1,873 | 1,820 | 1,751 | 1,654 | 1,379 | 1,234 | Upgrade
|
| Gross Profit | 1,003 | 1,130 | 1,136 | 1,178 | 767.8 | 605.7 | Upgrade
|
| Selling, General & Admin | 342.3 | 354.1 | 316 | 356.3 | 300.8 | 272.8 | Upgrade
|
| Research & Development | 69 | 68.4 | 58.5 | 52.8 | 46.9 | 38.9 | Upgrade
|
| Other Operating Expenses | -2.4 | -3 | -5.6 | -4.3 | -2.5 | -2 | Upgrade
|
| Operating Expenses | 408.9 | 419.5 | 368.9 | 404.8 | 345.2 | 309.7 | Upgrade
|
| Operating Income | 594.1 | 710.5 | 767.3 | 772.9 | 422.6 | 296 | Upgrade
|
| Interest Expense | -5 | -9 | -7.9 | -8.2 | -8.2 | -8.5 | Upgrade
|
| Interest & Investment Income | 24.2 | 28 | 5.1 | 1 | 1.4 | 3.8 | Upgrade
|
| Earnings From Equity Investments | 16 | 17.7 | 20.7 | 20.1 | 17.4 | 8.9 | Upgrade
|
| Currency Exchange Gain (Loss) | -13.7 | -9.4 | 4.1 | 1.4 | 1.5 | 4.6 | Upgrade
|
| EBT Excluding Unusual Items | 614.8 | 737.8 | 789.3 | 787.2 | 434.7 | 304.8 | Upgrade
|
| Merger & Restructuring Charges | 3 | 2 | -23.8 | -2.2 | -4.6 | -3 | Upgrade
|
| Gain (Loss) on Sale of Investments | -1 | -4.3 | -3.5 | -4.3 | -2.5 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | -11.6 | - | - | - | - | Upgrade
|
| Asset Writedown | -7.9 | -9.6 | -6.2 | -8.4 | -7.7 | -2.7 | Upgrade
|
| Legal Settlements | - | 3.8 | - | - | - | 4.7 | Upgrade
|
| Other Unusual Items | -4.1 | -2.4 | -55.2 | -3.3 | -1.2 | -3.1 | Upgrade
|
| Pretax Income | 604.8 | 715.7 | 700.6 | 769 | 418.7 | 300.7 | Upgrade
|
| Income Tax Expense | 105.2 | 122.3 | 114.7 | 107.2 | 72.5 | 59 | Upgrade
|
| Net Income | 499.6 | 593.4 | 585.9 | 661.8 | 346.2 | 241.7 | Upgrade
|
| Net Income to Common | 499.6 | 593.4 | 585.9 | 661.8 | 346.2 | 241.7 | Upgrade
|
| Net Income Growth | -10.69% | 1.28% | -11.47% | 91.16% | 43.24% | 16.82% | Upgrade
|
| Shares Outstanding (Basic) | 73 | 74 | 74 | 74 | 74 | 74 | Upgrade
|
| Shares Outstanding (Diluted) | 74 | 75 | 76 | 76 | 76 | 75 | Upgrade
|
| Shares Change (YoY) | -1.95% | -0.66% | -0.66% | 0.66% | 0.53% | - | Upgrade
|
| EPS (Basic) | 6.81 | 7.99 | 7.88 | 8.90 | 4.68 | 3.27 | Upgrade
|
| EPS (Diluted) | 6.74 | 7.88 | 7.73 | 8.67 | 4.57 | 3.21 | Upgrade
|
| EPS Growth | -9.12% | 1.94% | -10.84% | 89.72% | 42.37% | 17.15% | Upgrade
|
| Free Cash Flow | 321.6 | 414.5 | 439.4 | 330.6 | 298.1 | 240.8 | Upgrade
|
| Free Cash Flow Per Share | 4.34 | 5.50 | 5.80 | 4.33 | 3.93 | 3.19 | Upgrade
|
| Dividend Per Share | 0.800 | 0.770 | 0.730 | 0.690 | 0.650 | 0.610 | Upgrade
|
| Dividend Growth | 5.26% | 5.48% | 5.80% | 6.15% | 6.56% | 7.02% | Upgrade
|
| Gross Margin | 34.87% | 38.31% | 39.36% | 41.59% | 35.76% | 32.92% | Upgrade
|
| Operating Margin | 20.65% | 24.09% | 26.58% | 27.30% | 19.68% | 16.09% | Upgrade
|
| Profit Margin | 17.37% | 20.12% | 20.30% | 23.37% | 16.13% | 13.14% | Upgrade
|
| Free Cash Flow Margin | 11.18% | 14.05% | 15.22% | 11.68% | 13.89% | 13.09% | Upgrade
|
| EBITDA | 744.7 | 847.8 | 887.9 | 895.2 | 531.7 | 399.4 | Upgrade
|
| EBITDA Margin | 25.89% | 28.74% | 30.76% | 31.61% | 24.77% | 21.71% | Upgrade
|
| D&A For EBITDA | 150.6 | 137.3 | 120.6 | 122.3 | 109.1 | 103.4 | Upgrade
|
| EBIT | 594.1 | 710.5 | 767.3 | 772.9 | 422.6 | 296 | Upgrade
|
| EBIT Margin | 20.65% | 24.09% | 26.58% | 27.30% | 19.68% | 16.09% | Upgrade
|
| Effective Tax Rate | 17.39% | 17.09% | 16.37% | 13.94% | 17.32% | 19.62% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.